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Female reproduction is the only system subjected to well defined periodic changes. The final
stage of the menstrual cycle in mammals is the maturation of the ovum and the preparation of
the female organism to support fetal development fertilization. Once pregnancy occurs, both
maternal and fetal sites emit regulatory signals to ensure embryo development and maternal
protection against a graft versus host (GvH) reaction initiated by the semi-allogeneic fetus.
We and others have previously shown that each day of fetal development in mice is charac-
terized by different cytokine production, detected not only at the proximity of the feto-placen-
tal unit (decidua, uterus), but also in maternal lymphoid organs (spleen), as well as in the
serum. In the present study, we concentrated on the menstrual cycle and the preimplantation
stages of pregnancy and defined the levels of GM-CSF, IL-10, IL-6, and IL-3 in the murine
uterus during anoestrus, proestrus, oestrus, and second and third day of gestation. We show by
immunofluorescence and ELISA techniques that GM-CSF is maintained at high levels during
anoestrus, proestus, oestrus, and the second day of pregnancy while dropping on the third day.
IL-3 levels are found elevated during proestrus, second and third day of gestation, IL-6
increases essentially during proestrus, whereas the production of IL-10 was detected during
oestrus and the early stages of pregnancy. Immunoperoxidase staining on frozen sections of
uteri during the early gestational period localize GM-CSF and IL-3 production in the
endometrium, IL-10 in the endometrium on the second day of pregnancy, and
endometrium/myometrium on the third day. Low levels of IL-6 could be detected in the
endometrium/epithelium on the second day and endometrium/myometrium on the third day
of gestation. The role of IL-3, IL-10, and, to a lesser degree, IL-6 is fortified by the embryo
itself, since these cytokines were found to be produced by blastocysts as well. These results
demonstrate the existence of a specific distribution of lymphokines within the uterine tissue,
the role of which is being discussed.
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INTRODUCTION
The progression of events from ovum maturation to
fertilization and completion of pregnancy is highly
regulated by sex steroid hormones, cytokines, as well
as neuropeptides. The involvement of oestrogens, fol-
licule stimulating hormone (FSH), luterizing hormone
(LH), progesterone to ovum maturation, embryo
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implantation, and maintenance of pregnancy are
undisputable events, yet their action is still subject of
intense investigation.
It has been demonstrated that many cytokines play
important roles during the different stages of repro-
duction. Concentrating our interest on ovum matura-
tion and early pregnancy events, we can mention the
inhibitory role of tumor necrosis factor-o (TNF-c) to
steroid biosynthesis, sperm mobility, and sperm/cervi-
cal mucus interactions (Hill and Anderson, 1991).
IFN-y has also been reported to inhibit sperm mobility
(Hill and Anderson, 1989), whereas IL-I and CSF-1
are acting as implantation inhibitors during early
pregnancy (Haimovici et al., 1991; Tartakovsky et al.,
1991). Moreover, the involvement of neuropeptides
such as cortico-releasing hormone (CRH) and
-endorphin has also been postulated to monitor
embryo implantation (Makrigiannakis et al., 1995). It
appears thus that the study of these and other regula-
tory pathways is mandatory in order to understand the
fine reactions taking place in the uterus during the
menstrual cycle and early pregnancy.
In this paper, we study the intrauterine involvement
of granulocyte-macrop,hage colony stimulating factor
(GM-CSF), interleukin-3 (IL-3), interleukin-10 (IL-
l0), and interleukin-6 (IL-6) during the menstrual
cycle and postconceptional days of pregnancy in
mice. Although GM-CSF, IL-3, and IL-10 are known
to emit positive regulatory signals to trophoblasts and
late embryo development (Athanassakis et al., 1987;
Chaouat et al., 1990, 1995), their role in early stages
is debatable. We show that although a high percentage
of uterine cells synthezise GM-CSF during the men-
strual cycle, this cytokine is not secreted in high
amounts until the third day of pregnancy. Intracellular
IL-3 is expressed essentially during proestrus and the
third gestational day, but its secretion can only be
detected as pregnancy begins, reaching higher levels
on the third day. Secreted IL-10 can be detected after
the initiation of the gestational cycle, yet it can also be
detected intracellularly during oestrus. IL-6 is consid-
ered to be an inflammatory cytokine, harmful to the
late embryo (Heinrich et al., 1990), but possibly nec-
essary to initiate decidualization in the uterus. We
show that although IL-6 is intracellularly produced
during proestrus, it is secreted only in low amounts on
day 3 of pregnancy when implantation is expected to
take place. Immunohistological studies localize
GM-CSF and IL-3 positive cells until the fourth and
third day of pregnancy, respectively, in the
endometrium, IL-10 in the endometrium/myo-
metrium, whereas IL-6 can be detected sparsely into
endometrium, myometrium, as well as uterine epithe-
lium. IL-3, IL-10 and IL-6 production is also sup-
ported by the embryonic counterpart since these
cytokines were also found to be produced by blasto-
cysts.
RESULTS
Since the pattern of cytokine production during the
menstrual cycle and the first days of pregnancy is
essential to the female reproductive system, in the
present work, we concentrated on GM-CSF, IL-3,
IL-10, and IL-6 and determined the presence of intra-
cellular as well as secreted forms of these cytokines
during the menstrual cycle and the first days of preg-
nancy.
Thus, uteri from BALB/c females were isolated
and cultured for one to five days in order to determine
the best timing for lymphokine detection. Intracellular
immunofluorescence experiments showed that on the
third day of culture, all tested lymphokines wee
reaching maximal levels (Fig. 1), permitting thus to
concentrate on this day of culture for the rest of the
study. Five different stages of the reproductive cycle
were tested: anoestrus, proestrus, oestrus, and second
and third day of pregnancy. Cytokine production by
uterine cells was estimated by intracellular immun-
ofluorescence whereas their secretion was deter-
mined by indirect ELISA on the uterine cell culture
supernatants. Localization of the cytokines within the
uterine tissue was estimated by immunoperoxidase
staining of frozen uteri sections on days 2 to 5 of
pregnancy.CYTOKINES IN THE MURINE UTERUS 35
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FIGURE Determination of maximal cytokine production during
uterine cell cultures. Uterine cells were cultured for various time
intervals and intracellular cytokine production of GM-CSF (circle),
IL-3 (rectangle), IL-10 (triangle), and IL-6 (rhombus) was deter-
mined by immunofluorescence. The results represent the mean of
five different experiments performed using three mice every time.
In all cases, standard deviation varies from 2 to 6%.
GM-CSF
Higher production of this factor by the uterine cells is
seen during the menstrual cycle since 39-54% of the
cells produce GM-CSF, whereas this percentage
drops to 24 and 32% during the second and third day
of pregnancy, respectively (Fig. 2). Determination of
the extracellular presence of the cytokine reveals a
specific regulation between synthesis and secretion.
Only a small amount of GM-CSF is detected during
anoestrus, which increases to 35 and 30% over back-
ground during proestrus and oestrus, respectively.
Although on the second day of pregnancy the pres-
ence of GM-CSF in the culture medium remains at
low levels (19% of increase over background), it
remarkably reaches 99% of increase during the third
day (Fig. 3). Immunoperoxidase staining on frozen
sections of uteri localized GM-CSF in the
endometrium on the second, third, and fourth day of
gestation (Fig. 4).
IL-3
The highest percentage of IL-3-secreting cells during
the menstrual cycle is detected on the stage of proestrus
(42%), whereas 54% of the cells produce this
cytokine on the third day of pregnancy (Fig 2). How-
ever, the positive cells during proestrus do not seem
to secrete IL-3 since this factor could not be detected
in the culture supernatants in none of the stages of the
menstrual cycle. An increasing amount of the factor is
secreted after pregnancy begins, reaching 117% of
increase over background on the third day of preg-
nancy (Fig. 3), which correlates with immunoperoxi-
dase staining experiments when IL-3 is detected in
the endometrium on days 2 and 3 of pregnancy
(Fig. 4).
IL-6
IL-6-producing cells were essentially detected during
proestrus (Fig. 2), which, however, could not be
detected in culture supernatants (Fig. 3). This factor
was present at low levels (20% of increase over back-
ground) in the culture supernatants of uteri on the
third day of pregnancy. Immunoperoxidase stainings
detected smaller amounts of IL-6 in the
endometrium/epithelium on the second day, in the
endometrium/myometrium on the third and fourth
days, and endometrium on the fifth day of pregnancy
(Fig. 4).
IL-10
The percent of IL-10-producing cells enhances during
oestrus and follows an increasing phase after preg-
nancy occurs (Fig. 2), whereas secretion of the factor
is following a similar pattern (Fig. 3). IL-10 was
localized in the endothelium during the second day of
pregnancy and endometrium/myometrium during the
third and fifth day of gestation (Fig. 4).
Blastocyst Cytokine Production
If the cytokines studied here are important to implan-
tation, their uterine production should be enhanced by
fetal components as well. We therefore examined
whether blastocysts ensure production of these factors
by themselves, so that implantation may be facili-
tated. Immunofluorescence experiments on whole36 IRENE ATHANASSAKIS et al.
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FIGURE 2 Intracellular detection by immunofluorescence of GM-CSF, IL-3, IL-6, and IL-10 in cultured uterine cells during anoestrus (A),
proestrus (P), oestrus (O), days 2 and 3 of pregnancy (D2 and D3, respectively). The results represent the mean of 4 experiments and are
expressed as the net percentage of positive cells (background values, which varied from 3 to 7%, have been subtracted) _+ SD
blastocysts revealed the presence of IL-3 in trophec-
toderm and IL-10 in trophectoderm and inner cell
mass (Fig. 5). Low amounts of IL-6 were detected in
the trophectoderm, whereas GM-CSF could not be
detected neither in the trophectoderm nor inner cell
mass (data not shown).CYTOKINES IN THE MURINE UTERUS 37
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FIGURE 3 Secretion of GM-CSF, IL-3, IL-6, and IL-10 in uterine cell culture medium during anoestrus (A), proestrus (P), oestrus (O), days
2 and 3 of pregnancy (D2 and D3, respectively) as determined by ELISA. The results represent the mean of 4 experiments and are expressed
as the percent of optical density increase over background (O D values obtained in the absence of culture supernatants) _+ SD
DISCUSSION
It has become obvious that a number of cytokines are
involved in the regulation of the female reproductive
system. However, this system is not easily accessible
for an in depth study since it is submitted to continu-
ous changes during the menstrual cycle and the gesta-
tional period as well. In the present paper, we define
the profile of GM-CSF, IL-3, IL-6, and IL-10 in the
murine uterus during the menstrual cycle and the first38 IRENE ATHANASSAKIS et al.
FIGURE 4 Localization of GM-CSF, IL-3, IL-6, and IL-10 in uterine tissue frozen sections on days 2 to 5 of pregnancy by immunoperoxi-
dase staining. Microphotographs 10
postconceptional days. During the midgestational
period, GM-CSF and IL-3 have been shown to
improve fetal development by fortifying the placental
barrier (Athanassakis et al., 1987), whereas IL-10 has
been reported to rescue fetal rejection in experimental
abortion models (Chaouat et al., 1995). Except for
these three cytokines, which are positively involved
in fetal development, we have included in our study
IL-6, which is an inflammatory cytokine having
harmful effects at mid gestational stages, but not
studied for its effects during implantation. Following
immunofluorescence staining on uterine cells and
ELISA on the supernatants of the uterine cell cultures,
we were able to determine the intracellular production
and secretion of the cytokines studied. Immunoper-
oxidase staining on frozen uterine tissue section
localized the specific cytokine production from the
second to the fifth day of pregnancy.
We detected the intracellular presence of GM-CSF,
IL-3, IL-6, and IL- 10 during anoestrus, proestrus,CYTOKINES IN THE MURINE UTERUS 39
FIGURE 5 Detection of IL-3 and IL-10 in blastocysts by immunof-
luorescence staining. Microphotographs 40
oestrus as well as the second and third days of preg-
nancy. The results showed that GM-CSF was pro-
duced by a significant percentage of cells especially
during the menstrual cycle, IL-3 was essentially
detected during proestrus and the third day of preg-
nancy, IL-10 followed an increasing pattern from
oestrus to the third day of gestation, whereas signifi-
cant amounts of IL-6-positive cells were detected
during proestrus. However, these intracellularly local-
ized factors were not uniformly secreted in the culture
medium. The secretion of GM-CSF only on the third
day of pregnancy may indicate a probable important
role of this factor to blastocyst maturation. Other
investigators have shown that in vivo administration
of GM-CSF induces a high proportion of morulae, but
does not sustain normal implantation in vitro (Tartak-
ovsky and Ben-Yair, 1991). In order to determine the
duration of GM-CSF production, we immunostained
frozen sections of uteri from days 2 to 5 of pregnancy
and showed that GM-CSF levels decline on the fourth
and cannot be detected on the fifth day, indicating that
this factor is not needed until later in the pregnancy
(Athanassakis et al., 1987; Clark et al., 1994; Gar-
cia-Lloret et al., 1994).
The intracellular IL-3 observed during the men-
strual cycle is not secreted since it is undetectable in
the culture supernatants, indicating that it may be
involved in other intracellular pathways. Indeed, once
pregnancy begins, the amount of secreted IL-3
increases, reaching high levels on the third day. In
contrast to GM-CSF, immunoperoxidase staining on
frozen uterine sections cannot detect IL-3 on the
fourth or fifth day of pregnancy, indicating thus a pos-
sible necessity of the factor for blastocyst maturation
and implantation. The in situ experiments localize
GM-CSF and IL-3 production in the endometrium.
The observed higher amounts of the two cytokines
seen on day 2 of pregnancy, instead of day 3 as
expected from the ELISA and immunofluorescence
experiments, can be explained because on the second
day of pregnancy, GM-CSF and IL-3 are sparcely
produced by endometrial cells, whereas on the third
day, they are accumulated to implantation sites.
A similar analysis for IL-10 shows that only a low
amount of the intracellular factor is secreted essen-
tially during the first days of pregnancy. Immunohis-
tological analysis confirmed these results and
showed, in addition, the presence of this factor on the
fifth day of pregnancy. It therefore seems that except
for its protective role later in pregnancy (Chaouat et
al., 1995), IL-10 is required during the early stages of
fetal development as well. Despite the intracellular
localization of IL-10, the secretion of this factor is
less spectacular, indicating that the production and
secretion of the protein are regulated by different
intracellular mechanisms.
The inflammatory cytokine IL-6 is considered
harmful to embryo development since it may initiate
maternal antifetal immune response leading to fetal
rejection. However, one would expect to find IL-6
positively involved during early pregnancy to facili-
tate the local inflammatory reaction of implantation.
The high levels of intracellular IL-6 detected during
proestrus are in agreement with previous studies by
Prahala and Wira (1995), who showed that IL-6 facil-
itates maximal antigen presentation ability of the
female tract mucosal tissues during this stage of the
menstrual cycle. Immunohistological staining detects
IL-6 in all stages of pregnancy tested, showing a pos-
sible role of this factor during the early gestational
stage. Despite the intracellular production, as in the40 IRENE ATHANASSAKIS et al.
case of IL-10, IL-6 could be detected at low levels
only in the culture medium of day 3 pregnant uteri.
Immunofluorescence staining of blastocysts detect
IL-3 and IL-6 in trophectoderm, IL-10 in trophecto-
derm and inner cell mass, whereas GM-CSF could not
be found in any of the two populations, indicating that
uterine production for at least IL-3, IL-10, and IL-6 is
enhanced by the embryo itself, thus encouraging
maternal/fetal cross-talk.
This work defines the existence of specific cytokine
patterns during the menstrual cycle and the first days
of pregnancy in support of fetal development. Study-
ing the physiology of these early reproductive stages
is very useful to understanding many cases of infertil-
ity.
MATERIALS AND METHODS
Animals and Tissue Isolation
BALB/c mice were housed in the Animal Facility of
the University of Crete (Department of Biology), in
rooms with controlled light cycles (12L: 12D, lights
on at 0600 hr). Non pregnant uteri were collected
from sexually mature female mice (6 to 8 weeks old)
during the three phases of the menstrual cycle
(anoestrus, proestus, and oestrus). Pregnant uteri were
collected on days 2-5 of gestation. For the pre
implantation stages (days 2 and 3 of pregnancy),
female mice were supervolulated by receiving i.p. 5
IU of pregnant mare serum (PMS, Sigma, St. Louis)
at 1400 hr and 46 hr later 5 IU human chorionic gona-
dotropin (hCG, Sigma). Five hours after the last injec-
tion, the female mice were individually caged with
proven male breeders and examined for the presence
of vaginal plug the following morning, which was
considered as day zero of pregnancy. Before including
the uteri in the study, the presence of embryos in the
oviduct (day 2 of pregnancy) and uterus (day 3 of
pregnancy) was verified. For the collection of uteri on
days 4 and 5 of pregnancy, female mice were only
checked for oestrus and were individually caged over-
night with proven male breeders.
Antibodies
Rat anti-mouse IgG2a monoclonal antibodies to the
growth factors GM-CSF (sensitivity 5 tg/ml), IL-3
(sensitivity 3 tg/ml), IL- 10 (sensitivity 0.14 U/ml),
and IL-6 (sensitivity 50 pg/ml), purchased from
Endogen Inc. (Cambridge, MA), were used at the
concentration of tg/ml.
Blastocyst Collection
At 1100 hr on the third day of pregnancy, uteri were
isolated in M16 medium (Sigma) and supplemented
with 5% Fetal Calf Serum (FCS, Gibco, Grand Island,
NY). After removing the excess fat and mesentery,
uteri were flushed out using a torn Pasteur pipette.
Blastocysts collected in M16 medium were fixed in a
paraformaldehyde solution (3% PFA, Sigma). Blasto-
cysts were examined for the intracellular presence of
GM-CSE IL-3, IL-10, and IL-6 by immunofluores-
cerlce.
Cell Cultures
Uteri were put in a single cell suspension and cultured
in DMEM medium supplemented with 10% FCS
(Gibco, at a concentration of 1 106 cells/ml in
6-well plates (Nunc, Kampstrup, Denmark) for 2 to
five days. Culture supernatant was collected, centri-
fuged, and used in ELISA experiments, and at the
same time, uterine cells were submitted to immunof-
luorescence staining.
Enzyme-Linked lmmunoassays
Supernatant collected from days 2-4 of uterine cell
cultures were used at the dilution of 1:2 in carbonate
buffer pH 9.6. These were coated in 96-well flat bot-
tom plates (Sarstedt, Newton, NC), incubated over-
night at 4C, and washed four times in 5% Tween-20.
The remaining protein free sites in the plate were
blocked by 2% PBS-BSA solution after an inculation
of 2 hr at room temperature. After washing four
times, 100 tl of test antibodies diluted in 0.1%CYTOKINES IN THE MURINE UTERUS 41
PBS-BSA were added and incubated for 1 hr at room
temperature. Extensive washing of the plate was fol-
lowed by addition of 100 gl of goat anti-mouse IgG
coupled to horseradish peroxidase (1:1,000 dilution,
Sigma), which were incubated for hr at room tem-
perature, in the dark. Finally, the reaction was devel-
oped by adding 100 gl/well of tetramethyl
benzidine-H202 (Sigma) for 20 min. The enzymatic
reaction was stopped with 50 ].tl H2SO4 (4N). Optical
density (OD) was measured at 450 nm using a Titer-
tec ELISA photometer (Digiscan, ASYS Hitech
GmbH, Engendorf, Austria). Each experiment was
repeated at least four times. The results are expressed
as net OD values (+ SD, calculated from four or more
experiments), where control OD (coating buffer or
DMEM culture medium, where appropriate) was sub-
stracted from test values.
Indirect Immunofluorescence
Immunofluorescent staining of cytoplasmic growth
factor production was performed as described by
Sander et al. (1991). Uterine cells were scraped off
the culture plates and fixed with ice-cold paraformal-
dehyde (4% in PBS) for 5 min. After washing, the
cells were incubated for 30 min at room temperature
with specific antibodies diluted in HBSS-Saponin
solution (HBSS: Gibco, 0.01 M Hepes: Gibco, 0.1%
Saponin: Sigma). After washing in PBS-Saponin, the
cells were incubated with rabbit anti-rat IgG antibody
FITC-conjugated for 30 min at room temperature.
The cells were washed, fixed in 25% glycerol,
mounted on slides, and examined for cytoplasmic
staining using a Leitz fluorescent microscope. Blasto-
cysts were incubated in droplets containing the spe-
cific primary antibodies, washing medium, or
secondary FITC-conjugated antibody.
Immunoperoxidase Staining
Frozen uteri were mounted onto the cryostat using M-
1 embedding matrrix (U.K. Lipshaw, Germany) and
6-8 g sections were cut using a Leitz cryostat (Model
1720), The sections were collected on preheated
slides, fixed in acetone for 10 min, and kept at-20C
until used. For the immunoperoxidase staining, we
followed the technique described by Willingham
(1990). The sections were then counterstained with
Gill’s hematoxylin, dehydrated, mounted, and exam-
ined using a light microscope.
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